H.U. Group Holdings, Inc. (TYO:4544)
2,680.00
-58.00 (-2.12%)
Apr 2, 2025, 3:30 PM JST
H.U. Group Holdings Revenue
H.U. Group Holdings had revenue of 62.06B JPY in the quarter ending December 31, 2024, with 1.79% growth. This brings the company's revenue in the last twelve months to 241.49B, up 1.70% year-over-year. In the fiscal year ending March 31, 2024, H.U. Group Holdings had annual revenue of 236.95B, down -9.18%.
Revenue (ttm)
241.49B
Revenue Growth
+1.70%
P/S Ratio
0.63
Revenue / Employee
45.61M
Employees
5,295
Market Cap
152.27B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 236.95B | -23.96B | -9.18% |
Mar 31, 2023 | 260.91B | -12.04B | -4.41% |
Mar 31, 2022 | 272.94B | 49.93B | 22.39% |
Mar 31, 2021 | 223.02B | 34.30B | 18.18% |
Mar 31, 2020 | 188.71B | 7.30B | 4.02% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Daiichi Sankyo Company | 1,795.99B |
Takeda Pharmaceutical Company | 4,579.02B |
HOYA Corporation | 837.44B |
Otsuka Holdings | 2,329.86B |
Terumo | 1,011.15B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |